throbber
Does Repeated Heat Sterilization of Local
`Anesthetic Drugs Aflect Potency?
`
`L. Donald Bridenbaugh, M.D., and Daniel C. Moore, M.D.
`
`Samples of all the commonly used local anes-
`thetic drugs were autoclavcd for periods varying
`from 30 minutes to 3 hours. These were subse-
`quently assayed for potency. None of the drugs
`tested showed any appreciable loss of potency
`following autoclaving at 18 pounds pressure at
`260—275° F. for 8 hours.
`
`IN xu:cr..\"r years, theinecessity for heat steri-
`lization of
`local anesthetic drugs has been
`recognized. In some hospitals,
`if a sterilized
`ampule is not used it may be reautoclaved for
`a subsequent procedure;
`thus, some ampules
`may be subjected to several autoclavings be-
`fore use. However, as newer local anesthetic
`agents have become available, their tolerance
`to heat sterilization has not been adequately
`evaluated. The following questions may be
`raised: can all local anesthetic agents be heat
`sterilized without loss of anesthetic potency; if
`so, ho\v many times? This study was under-
`taken to answer these questions and to evaluate
`our method of heat
`sterilizaiton of
`local
`anesthetic drugs.
`
`Method of Study
`The commonly used local anesthetic agents
`were selected for testing,
`i.c., niphauoid crys-
`tals of tetracaine (Pontocaine),° and solutions
`of each of the following: procaine (Novocain),
`piperocaine (Metycaine), dibucaine (Nuper-
`caine), chloroprocaine
`(Nesacaine) mepiva-
`caine
`(Carbocaine),
`lidocaine
`(Xylocaine),
`and hexylcaine (Cyclaine).
`Six samples of
`each drug were selected and numbered 1
`through 6. The samples were subjected to
`heat sterilization in the unopened bottle or
`ampule as received from the pharmaceutical
`
`Accepted for publication December 20, 1963.
`The authors are in the Department of Anesthesi-
`ology, The Mason Clinic, Seattle, Washington.
`° Tetracaine crystals were used because this is
`the drug form used and recommended in our
`institution for regional anesthesia.
`
`372
`
`company. With the exception of one sample
`of each drug which served as a control, all
`others were placed in a regional block tray
`and autoelaved at .‘Z60—275° F. at 18 pounds
`pressure for 30 minutes. The trays were then
`cooled, one sample of each was removed and
`the time and number recorded. This process
`was repeated for each drug until
`there were
`samples which had been autoclaved for 30
`minutes, 60 minutes, 90 minutes, 120 minutes,
`and 180 minutes,
`respectively.
`This was
`equivalent to autoclaving the drug from one
`to six times under this system of sterilization.
`The numbered samples were then sent
`to
`the various drug manufacturers for assay of
`potency in a blind study.
`
`Results
`
`Procaine (2 per cent, 30 ml. vial), mepiva-
`caine (2 per cent, 50 ml. vial), and two sam-
`ples of
`tetracaiue
`(20 mg. and 250 mg.
`ampules of niphanoicl crystals) were sent to
`the manufacturer for assay. The results were
`reported as follows:
`samples were
`Procaine.
`Four milliliters
`made alkaline with 5 ml. of 10 per cent
`sodium carbonate solution and extracted 3
`times with 10-ml. volumes of
`chlorolonn.
`Thirty milliliters acetone was added to these
`extracts and the resulting solution titrated with
`0.1N acetous perchloric acid. Only intact
`procaine is measured in this technique. The
`percentage concentrations of the samples of
`procaine assayed were:
`Sample
`3
`
`l’eru-nlage Prnr-nine
`Control—— 1.91
`30 rniuutes—l.i)l
`60 minutes—l.!ll
`90 minutes—l.i)2
`1'20 miuutes—1.90
`180 minutcs—l.8‘J
`
`bdlGCJI‘.'1u$—
`
`MYLAN ET AL. - EXHIBIT 1020
`
`MYLAN ET AL. - EXHIBIT 1020
`
`

`
`l\"ll:rnt1:r"‘
`
`HEAT STERILIZATION AND LOCAL ANESTHETICS
`
`373
`
`The conclusion of the assay was: “Since one
`of the sarnples presumably represents a non-
`autoclazcd control, it follows that the slightly
`low as...1y values have nothing to do with the
`autoclaving;
`that
`is,
`there is no evidence of
`decomposition.”
`Tclrmrainc. Since there was a large number
`of tetracaine samples, selection for assay \vas
`made as follows: melting points were taken
`of the contents of each ampule. Those having
`a high melting point
`(145°—150° C.) were
`put aside as being of unquestioned excellence.
`Those with lower melting points were sub-
`jected
`to the more meaningful assay for
`p-hutylaminobenzoic acid (BABA),
`the hy-
`drolysis product of
`tetracaiue. Two of
`the
`20mg. size ampules and 5 of the 250-mg.
`size ampules were thus examined. The results
`are shown in table 1. These melting points
`demonstrate an interesting characteristic of
`tetracaine hydrochloride. This drug exists in
`three polymorphic crystalline fonns melting,
`respectively, at about 134° C., 130° C., and
`149° C.
`It generally consists of the highest
`melting form. Obviously, at autoclaved tem-
`peratures some conversion to the lower melting
`fonns occurs. However, further check was
`made for BABA. The values indicate negli-
`gible decomposition,
`if any, produced by
`nutoclaving.
`(2 per cent). Five-milliliter
`rllepiuacaine
`samples were made alkaline with 5 ml. of 10
`per cent sodium chloride and the solution ex-
`tracted 4 times with IS ml. of methylene
`
`'l‘.uu.r-1 1.
`
`Control
`30 minutes
`60 minutes
`90 minutes
`120 minutes
`180 minutes
`
`Percentage
`A mutant.MBA
`
`Results of Assays of 't'etrru-nine
`after Autoclaviug
`Melting: Point.
`(degrees ccntigmdc)
`’1‘etrncnine 20 mg.
`1-t5.6—1-16.8
`1-18.8-150.8
`145.2-140.0
`1303-13-1.8
`1-t6.0—l48.—t
`137.3-139.0
`
`0.07
`0.3
`
`Tetracn
`
`Control
`30 minutes
`(30 minutes
`90 minutes
`120 minutes
`180 minutes
`Pure drug
`
`inc 250 mg.
`121.8-133.2
`130.8—13-1.2
`135.~1—1~t2.2
`129.-1-135.4
`1~tti.8—l-19.2
`12-t.8—13-1.0
`1-15.0—150.0
`
`0.01
`0.02
`0.02
`0.02
`0.01
`0.02
`0.02
`
`’1‘.un.r-: 2.
`
`Results of Assays of .\Iepivacuinc
`After Autocluving
`
`S
`xiilliiill
`1
`2
`3
`4
`5
`6
`
`'
`.\ut1;'c'il.°»-ca
`180 minutes
`Control
`00 minutes
`00 minutes
`30 minutes
`120 minutes
`
`Vetting Point. of
`Percentage
`-I.
`.
`C°':§°{‘;{_fg‘°“ MI
`1.95
`In cacti case, the
`1.88
`melting point
`1.02
`of the e.\’tI'uclc(l
`1.91
`mepivncaine
`1.9!)
`base was be-
`2.00
`tween: 150°-
`153° C.
`
`TAHLE 3. Results of Second Study of Stul)ilit.y of Mepivncairie During Autocluving
`Melting Point of Extracted
`.\1cpi\'acnine Duo
`(degrees centigrulle)
`149.6—l5l.(i
`149.1-—l51.3
`t-1113-151 .0
`1~1t1.3—150.£)
`149.3-151.2
`1-t9.3—151.3
`
`1\|gnOl(l3l1I1:l\‘;Ed
`1
`2
`3
`«1
`5
`0
`1
`2
`3
`f.‘ 4
`5
`6
`
`\\'eig(lE§':7|t)Bnse
`0.0882
`0.0878
`0.0873
`0.0870
`0.0873
`0.0871
`0.0801
`0.0371
`0.0870
`0.0332
`0.0874
`0.0878
`
`file]
`
`0.1014
`0.1010
`0.1003
`1.1000
`1.1003
`1.1001
`0.0993
`0.1001
`1.1000
`0.1014
`0.1004
`1.1010
`
`Concelrtgpggiggct Drug
`2.03
`2.02
`2.01
`2.00
`2.01
`2.00
`1.08
`2.00
`2.00
`2.03
`2.01
`2.02
`
`11
`
`.
`1.
`
`tl1
`
`Exuiouucob
`
`

`
`374
`
`L. D. BRIDENBAUCH AND D. c. MOORE
`
`A...ai...aa..,,
`-‘[3!’-June 1964
`
`’1‘.un.r: «I. Results of Assays of Chlnroprorainc Mn-r Autoclaving
`
`Sm-mu.
`
`I
`2
`3
`-1
`5
`(i
`
`'”""‘.
`"'”"“'"""'
`
`1'20 minutes
`Control
`110 minutes
`180 minutes
`30 minutes
`60 minutes
`
`um.-1.
`
`(i00!)—00-I3
`6009-0l)«l3
`0009-0043
`(i0l2—05—
`
`6012-0525
`
`Wllalllilll-"'i'hl.)'l.T"
`prnrninn HCI
`
`""'“""“'=.“
`"3"""'>'-W
`
`3.58
`1.88
`1.88
`1.1!!)
`— — — Broken — — —
`L00
`-1.68
`1.97
`3,09
`1.95
`3.135
`
`These were pooled, dried with
`chloride.
`sodium sulfate, the sodium sulfate washed with
`several small portions of solvent. All solvent
`portions were then pooled and evaporated.
`The residues were weighed and the melting
`points taken (table 2). The values for samples
`2, 3, and 4 were slightly low, but
`it was
`thought unlikely that this indicated decompo-
`sition. More likely some analytical variation
`was involved.
`In order to verify this sup-
`position that only analytical variations were
`involved, additional assay was thought desir-
`able.
`In another test of stability twenty-four
`50-ml. commercial vials of 2 per cent mepiva-
`caine
`hydrochloride
`solution were
`used.
`Twelve were reserved as controls and twelve
`were autoclaved at 260° F.
`for 180 minutes
`at 20 pounds pressure. The autoclaved sam-
`ples were slightly discolored.
`Six of the con-
`trol vials and six of the autoclaved vials were
`assayed as before (table 3). These results
`apparently confirm the impression that mepiva-
`caine was not appreciably altered by heat
`sterilization and that minor variations in con-
`centration were due to analytical variation.
`Chloroprocaine. The autoclaved vials of 2
`per cent chloroprocaine were sent to the manu-
`
`TABLE 5. Assays of Samples of Same Lot. of
`Chloroprocainc After Autoclnvlng
`
`l
`l’
`.
`{‘;;;°,$:,':;3,§,g
`c...§§.E".2.l.‘:.“.’.’..e
`A,,3;;-;;,°,.,,,
`s..n...x..
`3.28
`1.95
`90 minutes
`1
`3.1 I
`1.98
`30 minutes
`2
`3-95
`1.98
`120 minutes
`3
`3.83
`1.95
`60 minutes
`-1
`1.10
`1.06
`Control
`5
`
`
`
`180 minutes 1.906 4.44
`
`facturer for assay. Sample 3 was broken in
`transit. The results of the analyses were re-
`ported as shown in table 4. REPORT: “It ap-
`pears that
`this experiment was set up with
`materials from two different lots.
`It would be
`desirable, if possible,
`to set up an experiment
`of this type with materials from the same lot.
`Label
`identifications were dilficult
`to read
`because of the breakage of a sample in transit."
`Because of the request for assay of samples all
`from the same lot six more bottles of 2 per cent
`chloroprocaine were autoclaved in the same
`manner. The assay was repeated and the
`results obtained as shown in table 5. REPom':
`"Since all of these vials came from our but
`1421,
`the initial assays on this lot were:
`percentage chloroprocaine HCl:1.97. Ap-
`parently there was no significant loss of potency
`from the repeated sterilization."
`Lidocaine (2 per cent).
`Lidocaine was
`subjected to both chemical and biological assay
`by the manufacturer (table 6). These results
`further support
`the established findings that
`lidocaine solutions, without epinephrine, may
`be reautoclaved without deterioration in bio-
`logical potency. The difference in the duration
`of motor block for the two sites of injection
`is due to the fact that the degree of vascularity
`of the two sites is different.
`Hexylcaine (2 per cent). The samples were
`assayed by the manufacturers for intact he.\'yl-
`caine
`hydrochloride
`and
`total
`hexylcaine
`hydrochloride (table 7).
`Piperominc (1.5 per cent 200 ml. vial)
`fonvarded to the manufacturer and analyzed
`for potency (method not
`reported).
`The
`results are shown in table 8. Since the theo-
`retical value is 15 mg./ml. (1.5 per cent), no
`significant decomposition is indicated during
`autoclaving of these samples.
`
`

`
`A |Im
`vVoIun£r“
`
`HEAT STERILIZATION AND LOCAL ANESTHETICS
`
`375
`
`'l‘Anl.l-I 6. Clu-micnl and llinlugit-nl .-\.‘i§l|_\‘S of l.i(lo('nin(- After Autm-lavin|.:
`
`~'.«-rilizinfl yiinw
`
`Siunnln
`
`l,"'l‘:'§“'l‘:)‘;fi"nlelCl
`
`1:11 Value
`
`(,'IwmiruI .-1ssa_:/: (Tests performed at room temperature of 73° 1".)
`
`Control
`:10 minutes
`60 minutes
`90 minutes
`I20 minutes
`1S0 minutes
`
`-1
`5
`1
`6
`3
`2
`
`1.98
`1.98
`1.98
`1.98
`1.98
`1.98
`
`6.62
`6.60
`6.62
`6.61
`6.60
`6.61
`
`I
`
`we
`
`.
`-
`-
`S‘°T':£:::"“
`
`
`
`cw
`
`
`
`-
`.
`'"e.;,ts"‘
`
`I
`
`"‘“ ‘““‘
`
`
`
`“““°''--i-
`
`
`
`"'°;'.a.;‘.'t?‘°'
`
`A '. D
`1'
`‘ J.‘.'.?§i;
`
`
`
`BiaIo_I/iml Asstty (wliilc rut srialir nerve injcrlion)
`
`-1
`5
`I
`6
`3
`‘2
`
`4
`5
`1
`6
`3
`2
`
`Control
`30 minutes
`60 minutes
`90 minutes
`120 minutes
`180 minutes
`
`Control
`30 minutes
`60 minutes
`90 minutes
`120 minutes
`180 minutes
`
`.
`
`I)
`E
`A
`F
`C
`B
`
`1)
`E
`A
`F
`C
`B
`
`0.1
`0.1
`0.1
`0.1
`0.1
`0.1
`
`0.2
`0.2
`0.2
`0.2
`0.2
`0.2
`
`R
`R
`R
`R
`R
`R
`
`L
`L
`L
`L
`L
`L
`
`Hip
`Hip
`Hip
`Hip
`Hip
`Hip
`
`.\1irlthig11
`.\1idthigh
`Midtliigli
`Mitlthigh
`.\li(lthigh
`Mitlthiglt
`
`12/12
`12/1‘.’.
`12/12
`12/12
`12/12
`1'2/12
`
`6/6
`5/6
`5/6
`5/6
`6/6
`6/6
`
`10-1
`8-!
`109
`101
`102
`I04
`
`103
`88
`85
`84
`90
`94
`
`Dilmcm'ne (121500, 20-ml. ampulc, each ml.
`containing 0.667 mg.) samples were sent
`to
`the manufacturer
`(method of assay not re-
`ported). The results are shown in table 9.
`1t is important to note that dibucaine in heavy
`solution should be resterilized only once be-
`cause further sterilization results in a darken-
`ing of the solution due to carmelization of
`the dextrose.
`
`Discussion
`the la\v suit of
`With the publication of
`the Ministry of
`Wooley and Roe versus
`Health,'~'-’ in which the legal decision stated
`that it was necessary to heat sterilize ampules
`of local anesthetics used for spinal anesthesia,
`the autoclaving of local anesthetics became
`establislied. However,
`there appeared to be
`no uniform method—some autoclaving the
`
`TABLE 7. Results of Assays of Hexylenine
`After Autoelaving
`
`TAIILE 8. Results of Assays of Piperocaino
`After Autoclaving
`
`-1
`6
`5
`2
`1
`3
`
`Control
`30 minutes
`60 minutes
`90 minutes
`120 minutes
`180 minutes
`
`19.6
`18.3"
`19.7
`17.8
`19.9
`16.8
`19.6
`17.5
`19.6
`17.1
`— — — Broken — — —
`
`1 (Lot 703119)
`2 (Lot. 703119)
`3 (Lot. 703119)
`4 (Lot 703119)
`5 (Lot. 703119)
`6 (Lot 727715)
`
`Control
`180 minutes
`90 minutes
`60 minutes
`120 minutes
`30 minutes
`
`1-1.7
`14.7
`1-1.7
`1-1.8
`14.7
`14.5
`
`3:17
`3.50
`3.40
`3.50
`3.39
`3.37
`
`

`
`376
`
`L. D. BRIDENBAUCH AND D. C. MOORE
`
`Anatliesiol
`.\lay—June lggty
`
`'I‘Am.l-: 9. Results of Assays of Dibucaino
`After Aulm-lnving
`
`Ampule
`1
`2
`3
`4
`5
`6
`
`Time .-\IItncln\'Nl
`90 minutes
`I20 minutes
`Control
`60 minutes
`180 minutes
`30 minutes
`
`0.65‘
`0.65‘
`0.65’
`0.65‘
`0.6-!‘
`0.61‘
`
`ampules in which the lumbar puncture sets,’
`some autoclaving only the ampules for spinal
`anesthesia, others advocating autoclaving all
`drugs and equipment used for regional anes-
`thesia.‘«‘v°
`Time and pressure techniques
`varied from 10 poundsfor 15 minutes to 20
`pounds for 45 minutes at the same tempera-
`ture.7
`In 1954, Whittet“ attempted to deter-
`mine the effects of multiple autoclaving of
`local anesthetic drugs for periods of from 1
`to 6 hours. There was deterioration within
`3 hours. The results of our study vary from
`Whittet’s study in that
`the tetracaine tested
`did not alter in potency after three hours of
`autoclaving. This may be due to the fact that
`both of the samples of tetraeaine tested con-
`sisted of niphanoid crystals, while that tested
`by Whittet was in solution, hence less stable.
`In the authors’ hospital, both heavy dibu-
`caine (l:200 in 6.0 per cent glucose) and
`heavy tetracaine (1 per cent in 10 per cent
`dextrose) are not autoclaved more than twice
`because of carmelization of the glucose and
`subsequent discoloration if heated longer than
`two hours.
`The results of the present study indicate
`that all of the commonly used local anesthetic
`drugs can be heat sterilized (18 pounds pres-
`sure, 260—275° F.
`for 30 minutes) at
`least
`6 times,
`for a total
`time of at
`least
`three
`hours without loss of potency. Cerlich et a1.“
`detennined that sterilization could be accom-
`plished at 15 pounds pressure and 250° F.
`temperature for 15 minutes. The system of
`heat sterilization using 18 pounds pressure at
`260-275“ F. for 30 minutes is recognized as
`being longer than necessary for sterilization
`of the drug. However, it was adopted because
`this is
`the routine for autoclaving surgical
`packs at our institution. Consequently,
`the
`regional block trays containing the local anes-
`thetic drugs could be included along with the
`
`surgical packs, thus decreasing the work neces.
`sary, and eliminating any special routine for
`sterilimtion. This system of autoclaving and
`reautoclaving of drugs has been in practice
`at our institution since 1953 and the drugs
`used in 30,979 cases without any case of in.
`fection or clinically observed loss of potency.
`
`Summary
`
`Heat sterilization of local anesthetic drugs
`has been established a necessity.
`In order
`to determine whether
`the newer anesthetic
`agents could be autoclaved without
`loss of
`potency and, if so, how many times, samples
`of all of the commonly used local anesthetic
`drugs were autoclaved for periods varying
`from 30 minutes to 3 hours.
`These were
`subsequently assayed by their manufacturers
`for potency. None of the agents tested showed
`any appreciable loss of potency following auto-
`claving at 18 pounds pressure, 260-275” F.
`for 3 hours.
`
`The authors wish to ex ress their gratitude to
`the research laboratories o Sterling-Winthrop In-
`stitutc, Strasenbur h Laboratories, Merck Sharp
`& Dohme Researci Laboratories, Astra Pl1am1a-
`ceutical Products,
`lnc., Eli Lilly and Company,
`and Ciba Phamiaceutical Company for their co-
`operation and aid in assa ing the dmg samples
`for potency following steri ization.
`References
`
`El!
`
`1.
`to
`
`.\ledico-Legal: Spinal anaesthetics appeals lail,
`Brit. Med. J. 1: 940, 1953.
`. Medico-Legal: Contaminated spinal anaesthetic,
`Brit. Med. J. 2: 1165, 1953.
`8. Walton, F. A.: Correspondence, A.\'E.S‘l'llF_§I-
`oLoc\' 13: 441, 1952.
`4. Bridenbaugh, L. 1)., and Moore, D. C.: Is heat
`sterilization of local anesthetic dmgs a ne-
`cessity?, ].A..\I.A. 168: 1334, 1958.
`Young, J. A., Collette, T. S., and Brehm, \V. F.:
`Sterility of multiple dose vials after repeated
`use, Amer. Surg. 24: 811, 1958.
`6. De Jong, R. H.:
`.\lultiple autoclaving of com-
`mercial
`local anesthetic solutions containing
`dilute epinephrine, ANes'r1n~:sio1.ocr 24: 582,
`1963.
`7. Carter, A. B., Herbert, C. L., DeWald, W. S.,
`and Talley, A. W.: Multiple autoclaving of
`drugs used in spinal anesthesia, ANes1'n£sr-
`or.ocr 15: 480, 1954.
`autoclaving in
`8. Whittet, T. D.: Effect of
`ampoulcs of local analgesics, Anaesthesia 9:
`271, 1954.
`9. Cerlich, N. A., Nicholas, P. S., and Ballingcr,
`C. M.: Heat sterilization of spinal anesthesia
`ampules (abstract), Am-;s11rEsroLocv 13: 164,
`1957.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket